Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
240
Trial Sponsor
Clinical Trial Start Date
July 9, 2022
0Primary Completion Date
July 19, 2022
0Study Completion Date
July 25, 2022
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
CT-L01 12.5/1,000 mg0
Interventional Trial Phase
Phase 10
Official Name
A Phase I, Randomized, Open-Label, Single-Dose, Crossover Study to Evaluate Food Effect on the Pharmacokinetics and Safety of CT-L01 After Oral Administration in Healthy Volunteers0
Last Updated
January 12, 2023
0Allocation Type
Randomized0
Intervention Model
Crossover Assignment0
Masking Type
None (Open Label)0
Study summary
This is a phase 1, randomized, open-label, single-dose, crossover, single-center study to evaluate food effect on the pharmacokinetics and safety of CT-L01 after oral administration in healthy volunteers.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
